LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $692,076 | -16.9% | 11,550 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $832,755 | +6.9% | 11,550 | +9.1% | 0.00% | 0.0% |
Q1 2023 | $779,074 | +99781.3% | 10,591 | -9.4% | 0.00% | -25.0% |
Q4 2022 | $780 | -22.5% | 11,684 | 0.0% | 0.00% | -20.0% |
Q3 2022 | $1,006 | -99.9% | 11,684 | +6.3% | 0.01% | 0.0% |
Q2 2022 | $980,000 | -21.2% | 10,988 | -0.6% | 0.01% | 0.0% |
Q1 2022 | $1,244,000 | -13.4% | 11,057 | +18.9% | 0.01% | 0.0% |
Q4 2021 | $1,437,000 | +8.7% | 9,300 | -1.9% | 0.01% | 0.0% |
Q3 2021 | $1,322,000 | +48.9% | 9,480 | +40.0% | 0.01% | +66.7% |
Q2 2021 | $888,000 | -14.0% | 6,770 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $1,032,000 | +41.6% | 6,770 | -7.7% | 0.00% | +33.3% |
Q4 2020 | $729,000 | -71.7% | 7,331 | -72.8% | 0.00% | -75.0% |
Q3 2020 | $2,574,000 | -14.8% | 27,000 | 0.0% | 0.01% | -20.0% |
Q2 2020 | $3,020,000 | +42.9% | 27,000 | +45.8% | 0.02% | +50.0% |
Q2 2019 | $2,114,000 | -16.8% | 18,522 | -8.3% | 0.01% | -23.1% |
Q1 2019 | $2,540,000 | -7.4% | 20,203 | 0.0% | 0.01% | -13.3% |
Q4 2018 | $2,742,000 | -27.8% | 20,203 | +46.1% | 0.02% | -16.7% |
Q3 2018 | $3,796,000 | +27.4% | 13,830 | -3.9% | 0.02% | +20.0% |
Q2 2018 | $2,980,000 | +21.2% | 14,385 | -3.4% | 0.02% | +15.4% |
Q1 2018 | $2,459,000 | +9.1% | 14,888 | -9.5% | 0.01% | +30.0% |
Q4 2017 | $2,253,000 | -1.2% | 16,452 | -1.8% | 0.01% | -16.7% |
Q3 2017 | $2,281,000 | +5.5% | 16,752 | -5.9% | 0.01% | +20.0% |
Q2 2017 | $2,162,000 | +14.7% | 17,811 | 0.0% | 0.01% | +11.1% |
Q1 2017 | $1,885,000 | +22.6% | 17,811 | +17.8% | 0.01% | +12.5% |
Q4 2016 | $1,537,000 | -0.4% | 15,123 | 0.0% | 0.01% | +14.3% |
Q3 2016 | $1,543,000 | -9.8% | 15,123 | +5.5% | 0.01% | -22.2% |
Q2 2016 | $1,710,000 | +11.4% | 14,338 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $1,535,000 | +1.1% | 14,338 | +2.4% | 0.01% | 0.0% |
Q4 2015 | $1,518,000 | +7.4% | 14,000 | 0.0% | 0.01% | +12.5% |
Q2 2015 | $1,413,000 | +29.0% | 14,000 | -1.4% | 0.01% | +33.3% |
Q1 2015 | $1,095,000 | +39.0% | 14,200 | -4.1% | 0.01% | +50.0% |
Q4 2014 | $788,000 | – | 14,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |